Medical ground mat and preparation process

Abstract

The invention relates to the technical field of preparation of medical supplies, in particular to a medical ground mat and a preparation process thereof.The preparation process comprises the steps that firstly, 60-80 parts of thermoplastic polyurethane, 20-40 parts of thermoplastic polyurethane, 5-10 parts of nano-silicon dioxide, 2-3 parts of silver-loaded zeolite and 3-5 parts of shape memory polymer are taken according to the proportion and mixed; then carrying out micro-foaming molding to obtain a preformed body; after precuring the preformed body at 60 DEG C, carrying out plasma activation treatment on the surface to obtain the elastic base material; the melt-blown fiber membrane subjected to 25 kV electrostatic electret treatment is compounded on the upper surface of the elastic base material in a hot-pressing mode; the microporous gel layer loaded with the slow-release disinfectant is adsorbed into the elastic base material in a vacuum mode, and a functional complex is obtained; in this way, the technical problems that in the prior art, the plasticity of a plasticine layer or a silica gel layer adopted in a dust removal pad is reduced after being pressed for a long time, the attaching degree of a dust removal film and a shoe sole is reduced, and use is affected are solved.

Description

Technical Field

[0001] This invention relates to the field of medical product manufacturing technology, and in particular to a medical floor mat and its manufacturing process. Background Technology

[0002] In medical environments, medical floor mats, as a fundamental and crucial medical product, play an irreplaceable, widespread, and profound role. They are widely used in various medical locations such as operating rooms, wards, treatment rooms, and examination rooms, acting like a silent guardian, undertaking multiple, complex, and vital functions. For example, a medical disinfection floor mat disclosed in prior art patent application number CN201620684911.5 includes a dust-removing mat, which consists of an elastic or plastic body at the bottom and a dust-removing membrane at the top. A disinfection mat is placed behind the dust-removing mat, located within a disinfection tank containing disinfectant. An absorbent mat is placed behind the disinfection mat. Further, the elastic or plastic body at the bottom of the dust-removing mat is a layer of modeling clay or silicone. This disinfection floor mat improves the performance of disinfection floor mats and is particularly suitable for use in locations with high requirements for dust and bacteria control.

[0003] However, in the above methods, the plasticity of the clay layer or silicone layer used in the dust removal mat decreases after long-term pressure, resulting in a reduced fit between the dust removal film and the shoe sole, affecting its use. Summary of the Invention

[0004] The purpose of this invention is to provide a medical floor mat and its manufacturing process, aiming to solve the technical problem in the prior art where the plasticity of the putty layer or silicone layer used in dust removal mats decreases after long-term pressure, resulting in a reduced fit between the dust removal film and the shoe sole, thus affecting its use.

[0005] To achieve the above objectives, the present invention employs a manufacturing process for a medical floor mat, comprising the following steps:

[0006] Take 60-80 parts, 20-40 parts of thermoplastic polyurethane, 5-10 parts of nano silica, 2-3 parts of silver-loaded zeolite, and 3-5 parts of shape memory polymer in proportion and add them to a mixing device for stirring and mixing to obtain a mixture;

[0007] The mixture is micro-foamed to obtain a preform;

[0008] After the preform is pre-cured at 60°C, the surface is subjected to plasma activation treatment to obtain an elastic substrate;

[0009] The meltblown fiber film treated with 25kV electrostatic electret is hot-pressed onto the surface of the elastic substrate.

[0010] A microporous gel layer containing a slow-release disinfectant is vacuum adsorbed into an elastic substrate to obtain a functional composite.

[0011] The functional complex is integrated with the chassis, which includes a dust removal area, a disinfection tank, a drying area, and an injection port connected to the disinfection tank.

[0012] Among them, when the microporous gel layer carrying the slow-release disinfectant is vacuum adsorbed into the elastic substrate, a vacuum adsorption optimization algorithm is introduced. The vacuum adsorption optimization algorithm precisely controls the vacuum degree and adsorption time of vacuum adsorption based on the pore structure of the elastic substrate, the characteristics of the microporous gel layer and the performance parameters of the vacuum adsorption equipment.

[0013] The specific method is as follows:

[0014] Pore ​​structure data of elastic substrates are obtained using pore structure analysis instruments;

[0015] Understanding the properties of microporous gel layers through materials analysis methods;

[0016] At the same time, the performance parameters of the vacuum adsorption equipment are obtained;

[0017] The above data is transmitted to the vacuum adsorption control system. The control system analyzes and calculates the appropriate vacuum level and adsorption time for this vacuum adsorption based on the preset pore structure-gel layer characteristics-equipment parameters-adsorption parameter model.

[0018] The control system sends control commands to the vacuum adsorption equipment to adjust the vacuum level and adsorption time, ensuring that the microporous gel layer can be uniformly and firmly adsorbed into the elastic substrate.

[0019] Among them, when hot-pressing the electrostatically electret treated meltblown fiber film onto the upper surface of the elastic substrate, a hot-pressing composite optimization algorithm is introduced. The hot-pressing composite optimization algorithm precisely controls the hot-pressing temperature, pressure and time based on the material characteristics and thickness of the elastic substrate and the meltblown fiber film, as well as the performance parameters of the hot-pressing equipment.

[0020] The specific method is as follows:

[0021] Material property data of elastic substrate and meltblown fiber film were obtained using material analysis instruments.

[0022] At the same time, obtain the performance parameters of the hot pressing equipment;

[0023] The above data is transmitted to the hot-pressing composite control system. The control system analyzes and calculates the hot-pressing temperature, pressure and time suitable for this hot-pressing composite based on the preset material-thickness-equipment parameters-hot-pressing parameter model.

[0024] The control system sends control commands to the hot pressing equipment to adjust the hot pressing temperature, pressure, and time, ensuring a good hot pressing composite effect between the elastic substrate and the meltblown fiber film.

[0025] During micro-foaming molding, the bubble pore size is 50-200μm, the porosity is 30-50%, and the surface is subjected to plasma activation treatment as follows:

[0026] An elastic substrate was prepared by plasma treatment with a 4:1 mixture of argon and oxygen at 300W power for 120-160s.

[0027] In the preparation of the mixture, 1-3 parts of dicyclopentadiene / urotropine microcapsules are added to the mixing equipment; these microcapsules are used to release monomers when cracks appear in the substrate, and the monomers are then polymerized in situ for repair under the action of a catalyst.

[0028] The microporous gel layer is formed by cross-linking poly(N-isopropylacrylamide) and sodium alginate, and the pore size varies with temperature.

[0029] The slow-release disinfectant contains chlorhexidine and chlorine dioxide microcapsules in a mass ratio of 1:2, and the microcapsule wall material is ethyl cellulose.

[0030] The shape memory polymer is polycaprolactone-type polyurethane with a phase change temperature of 35-40℃. When the foot pressure is greater than 10 kPa, it undergoes phase change flow to fill the microcracks.

[0031] The present invention also provides a medical floor mat, which is manufactured using the medical floor mat manufacturing process described above.

[0032] The device includes a chassis, a dust removal component, a disinfection pad, and a disinfection screen. The chassis has a dust removal area, a disinfection tank, a drying area, and an injection hole. The injection hole is connected to the disinfection tank. The dust removal component is located in the dust removal area, and the disinfection pad and the disinfection screen are both located in the disinfection area.

[0033] This invention discloses a medical floor mat and its preparation process. In practical use, 60-80 parts of thermoplastic polyurethane, 20-40 parts of nano-silica, 5-10 parts of silver-loaded zeolite, and 3-5 parts of shape memory polymer are first added to a mixing device and stirred to obtain a mixture. The mixture is then micro-foamed to obtain a preform. After pre-curing the preform at 60°C, the surface is plasma-activated to obtain an elastic substrate. A meltblown fiber membrane treated with 25kV electrostatic electret is hot-pressed onto the surface of the elastic substrate. A microporous gel layer carrying a slow-release disinfectant is vacuum-adsorbed into the elastic substrate to obtain a functional composite. The functional composite is integrated with a chassis, which includes a dust removal area, a disinfection tank, a drying area, and an injection hole connecting to the disinfection tank. This method solves the technical problem in existing dust removal mats where the plasticity of the putty layer or silicone layer decreases after long-term pressure, leading to reduced adhesion between the dust removal membrane and the shoe sole, affecting usability. Attached Figure Description

[0034] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the drawings used in the description of the embodiments or the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.

[0035] Figure 1 This is a flowchart of the medical floor mat and its preparation process according to the present invention.

[0036] Figure 2 This is a top view of the medical floor mat of the present invention.

[0037] Figure 3 This is a cross-sectional view of the medical floor mat of the present invention.

[0038] 1-Chassis, 2-Dust removal components, 3-Disinfection pad, 4-Disinfection net, 5-Dust removal area, 6-Disinfection tank, 7-Drying area, 8-Injection hole. Detailed Implementation

[0039] The embodiments of the present invention are described in detail below. Examples of the embodiments are shown in the accompanying drawings. The embodiments described below with reference to the accompanying drawings are exemplary and intended to explain the present invention, but should not be construed as limiting the present invention.

[0040] Please see Figure 1 , Figure 1 This is a flowchart of the medical floor mat and its preparation process according to the present invention.

[0041] This invention provides a medical floor mat and its manufacturing process, comprising the following steps:

[0042] S1. Take 60-80 parts, 20-40 parts of thermoplastic polyurethane, 5-10 parts of nano silica, 2-3 parts of silver-loaded zeolite, and 3-5 parts of shape memory polymer according to the proportion and add them to the mixing equipment for stirring and mixing to obtain a mixture;

[0043] In this specific embodiment, when preparing the mixture, 1-3 parts of dicyclopentadiene / urotropine microcapsules and 1-2 parts of pre-dispersed Grubbs catalyst are added to the mixing equipment; this is used to release monomers by rupturing the microcapsules when cracks appear in the substrate, and to repair them in situ through polymerization under the action of the catalyst.

[0044] The shape memory polymer is polycaprolactone-type polyurethane with a phase change temperature of 35-40℃. When the foot pressure is greater than 10 kPa, it undergoes phase change flow to fill the microcracks.

[0045] S2. The mixture is micro-foamed to obtain a preform;

[0046] In this specific embodiment, during microfoaming molding: the bubble pore size is 50-200μm, the porosity is 30-50%, and the surface is subjected to plasma activation treatment as follows:

[0047] An elastic substrate was prepared by plasma treatment with a 4:1 mixture of argon and oxygen at 300W power for 120-160s.

[0048] S3. After the preform is pre-cured at 60°C, the surface is subjected to plasma activation treatment to obtain an elastic substrate.

[0049] In this specific embodiment, the surface is subjected to plasma activation treatment as follows:

[0050] An elastic substrate was prepared by plasma treatment with a 4:1 mixture of argon and oxygen at 300W power for 120-160s.

[0051] S4. Hot-press the meltblown fiber film treated with 25kV electrostatic electret onto the upper surface of the elastic substrate.

[0052] In this specific embodiment, the microporous gel layer is cross-linked from poly(N-isopropylacrylamide) and sodium alginate, and the pore size varies with temperature.

[0053] S5. Vacuum adsorption of the microporous gel layer containing the slow-release disinfectant into the elastic substrate to obtain a functional composite.

[0054] In this specific embodiment, the slow-release disinfectant comprises chlorhexidine and chlorine dioxide microcapsules in a mass ratio of 1:2, and the microcapsule wall material is ethyl cellulose.

[0055] S6. Integrate the functional complex with the chassis 1. The chassis 1 is provided with a dust removal area 5, a disinfection tank 6, a drying area 7 and an injection hole 8 that connects to the disinfection tank 6.

[0056] When vacuum adsorbing a microporous gel layer carrying a slow-release disinfectant into an elastic substrate, a vacuum adsorption optimization algorithm is introduced. The vacuum adsorption optimization algorithm precisely controls the vacuum degree and adsorption time of vacuum adsorption based on the pore structure of the elastic substrate, the characteristics of the microporous gel layer, and the performance parameters of the vacuum adsorption equipment.

[0057] The specific method is as follows:

[0058] Pore ​​structure data of elastic substrates are obtained using pore structure analysis instruments;

[0059] Understanding the properties of microporous gel layers through materials analysis methods;

[0060] At the same time, the performance parameters of the vacuum adsorption equipment are obtained;

[0061] The above data is transmitted to the vacuum adsorption control system. The control system analyzes and calculates the appropriate vacuum level and adsorption time for this vacuum adsorption based on the preset pore structure-gel layer characteristics-equipment parameters-adsorption parameter model.

[0062] The control system sends control commands to the vacuum adsorption equipment to adjust the vacuum level and adsorption time, ensuring that the microporous gel layer can be uniformly and firmly adsorbed into the elastic substrate.

[0063] When hot-pressing electrostatically electret treated meltblown fiber film onto the surface of an elastic substrate, a hot-pressing composite optimization algorithm is introduced. The hot-pressing composite optimization algorithm precisely controls the hot-pressing temperature, pressure and time based on the material characteristics and thickness of the elastic substrate and meltblown fiber film, as well as the performance parameters of the hot-pressing equipment.

[0064] The specific method is as follows:

[0065] Material property data of elastic substrate and meltblown fiber film were obtained using material analysis instruments.

[0066] At the same time, obtain the performance parameters of the hot pressing equipment;

[0067] The above data is transmitted to the hot-pressing composite control system. The control system analyzes and calculates the hot-pressing temperature, pressure and time suitable for this hot-pressing composite based on the preset material-thickness-equipment parameters-hot-pressing parameter model.

[0068] The control system sends control commands to the hot pressing equipment to adjust the hot pressing temperature, pressure, and time, ensuring a good hot pressing composite effect between the elastic substrate and the meltblown fiber film.

[0069] Example 1:

[0070] In this embodiment, the manufacturing process of the medical floor mat is as follows:

[0071] Take 60 parts, 20 parts of thermoplastic polyurethane, 5 parts of nano silica, 2 parts of silver-loaded zeolite, and 3 parts of shape memory polymer in proportion and add them to a mixing device for stirring and mixing. During the mixing process, add 1 part of dicyclopentadiene / urotropine microcapsules and 1 part of pre-dispersed Grubbs catalyst to obtain a mixture.

[0072] The mixture is micro-foamed to obtain a preform;

[0073] After the preform is pre-cured at 60°C, the surface is subjected to plasma activation treatment to obtain an elastic substrate;

[0074] The meltblown fiber film treated with 25kV electrostatic electret is hot-pressed onto the surface of the elastic substrate.

[0075] A microporous gel layer containing a slow-release disinfectant is vacuum adsorbed into an elastic substrate to obtain a functional composite.

[0076] The functional complex is integrated with the chassis 1, which is provided with a dust removal area 5, a disinfection tank 6, a drying area 7, and an injection hole 8 that connects to the disinfection tank 6.

[0077] Example 2:

[0078] In this embodiment, the manufacturing process of the medical floor mat is as follows:

[0079] Take 70 parts, 30 parts of thermoplastic polyurethane, 7.5 parts of nano silica, 2.5 parts of silver-loaded zeolite, and 4 parts of shape memory polymer in proportion and add them to a mixing device for stirring and mixing. During the mixing process, add 2 parts of dicyclopentadiene / urotropine microcapsules and 1.5 parts of pre-dispersed Grubbs catalyst to obtain a mixture.

[0080] The mixture is micro-foamed to obtain a preform;

[0081] After the preform is pre-cured at 60°C, the surface is subjected to plasma activation treatment to obtain an elastic substrate;

[0082] The meltblown fiber film treated with 25kV electrostatic electret is hot-pressed onto the surface of the elastic substrate.

[0083] A microporous gel layer containing a slow-release disinfectant is vacuum adsorbed into an elastic substrate to obtain a functional composite.

[0084] The functional complex is integrated with the chassis 1, which is provided with a dust removal area 5, a disinfection tank 6, a drying area 7, and an injection hole 8 that connects to the disinfection tank 6.

[0085] Example 3:

[0086] In this embodiment, the manufacturing process of the medical floor mat is as follows:

[0087] Take 80 parts, 40 parts of thermoplastic polyurethane, 10 parts of nano silica, 3 parts of silver-loaded zeolite, and 5 parts of shape memory polymer in proportion and add them to a mixing device for stirring and mixing. During the mixing process, add 3 parts of dicyclopentadiene / urotropine microcapsules and 2 parts of pre-dispersed Grubbs catalyst to obtain a mixture.

[0088] The mixture is micro-foamed to obtain a preform;

[0089] After the preform is pre-cured at 60°C, the surface is subjected to plasma activation treatment to obtain an elastic substrate;

[0090] The meltblown fiber film treated with 25kV electrostatic electret is hot-pressed onto the surface of the elastic substrate.

[0091] A microporous gel layer containing a slow-release disinfectant is vacuum adsorbed into an elastic substrate to obtain a functional composite.

[0092] The functional complex is integrated with the chassis 1, which is provided with a dust removal area 5, a disinfection tank 6, a drying area 7, and an injection hole 8 that connects to the disinfection tank 6.

[0093] The surface of the plasma-treated elastic substrate develops nanoscale pits with a depth of 200-500 nm and a density of 10. 5 -10 6 pcs / cm2

[0094] After integrating the functional complex with chassis 1, a turbidity sensor is installed at the bottom of chassis 1.

[0095] Using the preparation process of a medical floor mat according to the present invention, in specific use, firstly, 60-80 parts, 20-40 parts of thermoplastic polyurethane, 5-10 parts of nano-silica, 2-3 parts of silver-loaded zeolite, and 3-5 parts of shape memory polymer are added to a mixing device and stirred to obtain a mixture; then, the mixture is micro-foamed to obtain a preform; after the preform is pre-cured at 60°C, the surface is plasma-activated to obtain an elastic substrate; a meltblown fiber membrane treated with 25kV electrostatic electret is hot-pressed onto the upper surface of the elastic substrate; a microporous gel layer carrying a slow-release disinfectant is vacuum-adsorbed into the elastic substrate to obtain a functional composite; the functional composite is integrated with a chassis 1, the chassis 1 being provided with a dust removal area 5, a disinfection tank 6, a drying area 7, and an injection hole 8 connecting to the disinfection tank 6. This method solves the technical problem in the prior art where the plastic clay layer or silicone layer used in dust removal mats loses plasticity after long-term pressure, resulting in reduced adhesion between the dust removal membrane and the shoe sole, affecting its use.

[0096] This invention addresses the problem in existing technologies where the plasticity of the putty layer or silicone layer decreases after long-term pressure, leading to a reduced fit between the dust removal film and the shoe sole. This is achieved by adding a shape memory polymer (polycaprolactone-type polyurethane) to the mixture, which has a phase change temperature of 35-40℃. When the foot pressure is greater than 10kPa, a phase change flow occurs to fill the microcracks. This effectively solves the problem of reduced plasticity of the putty layer or silicone layer after long-term pressure, leading to a reduced fit between the dust removal film and the shoe sole. This ensures the long-term performance of the medical floor mat.

[0097] The dicyclopentadiene / urotropine microcapsules added in this invention can rupture and release monomers when cracks appear in the substrate. Under the action of a catalyst, they can be polymerized and repaired in situ, further extending the service life of the medical floor mat, reducing the frequency of replacement, and lowering the cost of use.

[0098] By introducing vacuum adsorption optimization algorithms and hot-pressing composite optimization algorithms, the vacuum degree and adsorption time of vacuum adsorption and the hot-pressing temperature, pressure and time of hot-pressing composite are precisely controlled, respectively. This ensures that the microporous gel layer can be uniformly and firmly adsorbed in the elastic substrate, and that the elastic substrate and meltblown fiber membrane achieve a good hot-pressing composite effect, thereby improving the overall quality and performance stability of the medical floor mat.

[0099] The microporous gel layer is cross-linked from poly(N-isopropylacrylamide) and sodium alginate, with pore size exhibiting a gradient change with temperature. This characteristic allows the microporous gel layer to adjust its adsorption and release of disinfectants according to different ambient temperatures, thus improving disinfection efficacy. The slow-release disinfectant contains chlorhexidine and chlorine dioxide microcapsules in a 1:2 mass ratio. The microcapsule wall material is ethyl cellulose, enabling slow release of the disinfectant, extending disinfection time, and providing long-lasting disinfection protection for the medical environment.

[0100] Please see Figure 2 and Figure 3 , Figure 2 This is a top view of the medical floor mat of the present invention. Figure 3 This is a cross-sectional view of the medical floor mat of the present invention.

[0101] The present invention also provides a medical floor mat, which is manufactured using the medical floor mat manufacturing process described above.

[0102] The device includes a chassis 1, a dust removal component 2, a disinfection pad 3, and a disinfection net 4. The chassis 1 has a dust removal area 5, a disinfection tank 6, a drying area 7, and an injection hole 8. The injection hole 8 is connected to the disinfection tank 6. The dust removal component 2 is disposed in the dust removal area 5. The disinfection pad 3 and the disinfection net 4 are both disposed in the disinfection area. A drying pad 9 is disposed in the drying area 7.

[0103] The above description discloses only one preferred embodiment of the present invention, and should not be construed as limiting the scope of the present invention. Those skilled in the art will understand that all or part of the processes of the above embodiments can be implemented, and equivalent changes made in accordance with the claims of the present invention are still within the scope of the invention.

Claims

1. A manufacturing process for a medical floor mat, characterized in that, Includes the following steps: Take 60-80 parts, 20-40 parts of thermoplastic polyurethane, 5-10 parts of nano silica, 2-3 parts of silver-loaded zeolite, and 3-5 parts of shape memory polymer in proportion and add them to a mixing device for stirring and mixing to obtain a mixture; The mixture is micro-foamed to obtain a preform; After the preform is pre-cured at 60°C, the surface is subjected to plasma activation treatment to obtain an elastic substrate; The meltblown fiber film treated with 25kV electrostatic electret is hot-pressed onto the surface of the elastic substrate. A microporous gel layer containing a slow-release disinfectant is vacuum adsorbed into an elastic substrate to obtain a functional composite. The functional complex is integrated with the chassis, which includes a dust removal area, a disinfection tank, a drying area, and an injection port connected to the disinfection tank.

2. The manufacturing process of the medical floor mat as described in claim 1, characterized in that, When vacuum adsorbing a microporous gel layer carrying a slow-release disinfectant into an elastic substrate, a vacuum adsorption optimization algorithm is introduced. The vacuum adsorption optimization algorithm precisely controls the vacuum degree and adsorption time of vacuum adsorption based on the pore structure of the elastic substrate, the characteristics of the microporous gel layer, and the performance parameters of the vacuum adsorption equipment. The specific method is as follows: Pore ​​structure data of elastic substrates are obtained using pore structure analysis instruments; Understanding the properties of microporous gel layers through materials analysis methods; At the same time, the performance parameters of the vacuum adsorption equipment are obtained; The above data is transmitted to the vacuum adsorption control system. The control system analyzes and calculates the appropriate vacuum level and adsorption time for this vacuum adsorption based on the preset pore structure-gel layer characteristics-equipment parameters-adsorption parameter model. The control system sends control commands to the vacuum adsorption equipment to adjust the vacuum level and adsorption time, ensuring that the microporous gel layer can be uniformly and firmly adsorbed into the elastic substrate.

3. The manufacturing process of the medical floor mat as described in claim 2, characterized in that, When hot-pressing electrostatically electret treated meltblown fiber film onto the surface of an elastic substrate, a hot-pressing composite optimization algorithm is introduced. The hot-pressing composite optimization algorithm precisely controls the hot-pressing temperature, pressure and time based on the material characteristics and thickness of the elastic substrate and meltblown fiber film, as well as the performance parameters of the hot-pressing equipment. The specific method is as follows: Material property data of elastic substrate and meltblown fiber film were obtained using material analysis instruments. At the same time, obtain the performance parameters of the hot pressing equipment; The above data is transmitted to the hot-pressing composite control system. The control system analyzes and calculates the hot-pressing temperature, pressure and time suitable for this hot-pressing composite based on the preset material-thickness-equipment parameters-hot-pressing parameter model. The control system sends control commands to the hot pressing equipment to adjust the hot pressing temperature, pressure, and time, ensuring a good hot pressing composite effect between the elastic substrate and the meltblown fiber film.

4. The manufacturing process of the medical floor mat as described in claim 3, characterized in that, During micro-foaming molding: bubble pore size 50-200μm, porosity 30-50%; The surface is activated by plasma as follows: An elastic substrate was prepared by plasma treatment with a 4:1 mixture of argon and oxygen at 300W power for 120-160s.

5. The manufacturing process of the medical floor mat as described in claim 4, characterized in that, When preparing the mixture, add 1-3 parts of dicyclopentadiene / urotropine microcapsules and 1-2 parts of pre-dispersed Grubbs catalyst into the mixing equipment.

6. The manufacturing process of the medical floor mat as described in claim 5, characterized in that, The microporous gel layer is formed by cross-linking poly(N-isopropylacrylamide) and sodium alginate, and the pore size varies with temperature.

7. The manufacturing process of the medical floor mat as described in claim 6, characterized in that, The slow-release disinfectant contains chlorhexidine and chlorine dioxide microcapsules in a mass ratio of 1:2, and the microcapsule wall material is ethyl cellulose.

8. The manufacturing process of the medical floor mat as described in claim 7, characterized in that, The shape memory polymer is polycaprolactone-type polyurethane with a phase change temperature of 35-40℃. When the foot pressure is greater than 10 kPa, it undergoes phase change flow to fill the microcracks.

9. A medical floor mat, manufactured using the medical floor mat manufacturing process as described in claim 8, characterized in that, The device includes a chassis, a dust removal component, a disinfection pad, and a disinfection screen. The chassis has a dust removal area, a disinfection tank, a drying area, and an injection hole. The injection hole is connected to the disinfection tank. The dust removal component is located in the dust removal area, and the disinfection pad and the disinfection screen are both located in the disinfection area.

Images